Literature DB >> 8402060

Pattern of recurrence after hepatic resection for colorectal metastases.

K Sugihara1, K Hojo, Y Moriya, S Yamasaki, T Kosuge, T Takayama.   

Abstract

Between 1978 and 1989, 159 patients with liver metastases from colorectal cancer underwent hepatic resection. Of 134 patients in whom metastases were confined to the liver, 109 had tumours removed completely with histologically negative resection margins. Two patients died in hospital. Ultrasonographically guided partial resection was performed in 80 patients, lateral segmentectomy in seven and lobectomy in 22. The 5-year survival rate of patients undergoing potentially curative resection was 47.9 per cent. Patients with metachronous tumours showed a significantly better prognosis than those with synchronous lesions in both univariate (P < 0.01) and multivariate (P = 0.01) analysis. During a median follow-up of 35.4 months, 64 patients developed recurrence, including 34 in the liver, 20 in the lung and 12 in the abdominal cavity. Of those with hepatic recurrence, ten patients developed tumours at the initial resection bed, seven in the same lobe, five in the contralateral lobe and 12 in both lobes. Ultrasonographically guided partial liver resection did not increase the risk of hepatic recurrence.

Entities:  

Mesh:

Year:  1993        PMID: 8402060     DOI: 10.1002/bjs.1800800837

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  34 in total

Review 1.  The surgical treatment of hepatic metastases in colorectal carcinoma.

Authors:  Ulf Peter Neumann; Daniel Seehofer; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2010-05-14       Impact factor: 5.594

2.  Indicators for treatment strategies of colorectal liver metastases.

Authors:  H Ueno; H Mochizuki; K Hatsuse; K Hase; T Yamamoto
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 3.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases.

Authors:  Takashi Matsui; Tosuke Kitamura; Heita Ozawa; Haruhisa Matsuguma; Kenjiro Kotake
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

Review 5.  Colorectal cancer and the liver.

Authors:  I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1997-09       Impact factor: 1.891

6.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

7.  Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer.

Authors:  Masaki Kaibori; Yoshinori Iwamoto; Morihiko Ishizaki; Kosuke Matsui; Kazuhiko Yoshioka; Hiroaki Asano; A-Hon Kwon
Journal:  Langenbecks Arch Surg       Date:  2011-10-22       Impact factor: 3.445

8.  [Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors].

Authors:  J K Seifert; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1996

9.  Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease?

Authors:  M Franklin; J Trevino; H Hernandez-Oaknin; T Fisher; K Berghoff
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

10.  Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors.

Authors:  Ikuo Nagashima; Tadahiro Takada; Miki Adachi; Hirokazu Nagawa; Tetsuichiro Muto; Kota Okinaga
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.